← All claims

Metabolic & Cardiometabolic

MTHFR C677T increases homocysteine

Strong support Metabolic & Cardiometabolic

Part of: • MTHFR C677T

RefutedContestedStrong support
consensus score 1.00

📅 Last reviewed: 2026-07-15

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Population patterns (Observational)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

11 support 0 contradict 0 tested null 0 mixed · 11 sources, 11 independent groups

What the evidence shows

The MTHFR C677T TT genotype is associated with higher serum homocysteine in women with PCOS (reduced enzyme activity → impaired homocysteine remethylation). Mechanistic basis for the vascular/stroke-risk thread.

The evidence (11)

SourceGradeStanceQualityFinding
Song J et al
2026 · study_type: observational
observational supports medium N. China diabetic-nephropathy cohort (n=397): Hcy 17.29±8.95 (TT) vs 13.08±6.20 (CT) vs 12.65±4.35 µmol/L (CC), p<0.001; TT genotype 12.7x risk of nephropathy vs CC.
Zhao J, Li X, Chen Q
2024 · Gene
observational supports moderate [FT-verified] Zhao 2024 PCOS n=104 TT Hcy>CT>CC; confirms scoped PCOS appraisal
Zhou R et al
2025 · study_type: observational
observational supports moderate Large infertility cohort (n=6344): serum Hcy significantly higher in MTHFR 677CT and TT vs CC (p<0.001 for both); Hcy mediated 15.8% (CT) and 41.6% (TT) of the genotype–vitamin-D-deficiency association.
Shareef ZA et al
2025 · study_type: observational
observational supports moderate Iraqi Kurdish T2DM cross-sectional: TT genotype associated with higher homocysteine (22.08±5.74 µmol/L) and lower HDL-C vs other genotypes; CC/CT comparator values not given in abstract.
Oliveira IO et al] # corrected 2026-08-17 from PubMed; was [et al.
2017 · Eur J Clin Nutr
observational supports moderate MTHFR C677T TT raises homocysteine (modified by smoking/alcohol).
Oliveira APG et al] # corrected 2026-08-17 from PubMed; was [et al.
2024 · Diagn Microbiol Infect Dis
observational supports moderate [FT-verified] Oliveira 2024 H.pylori n=168 TT assoc higher Hcy; independent beyond PCOS
Jin M et al
2022 · study_type: observational
observational supports medium Han Chinese case-control (1810 LAAIS cases, 1765 controls): plasma Hcy genotype-dependent trend TT > CT > CC (no exact values/CI given in abstract).
Oh S et al
2026 · study_type: observational
observational supports low Case report: homozygous C677T, plasma Hcy >50µmol/L with concurrent folate deficiency; severe thrombosis; Hcy improved with folate/B6 repletion.
Akácsos-Szász OZ et al
2026 · study_type: observational
observational supports low PAD cohort, severe cases (n=31): homozygous MTHFR mutation carriers had significantly higher homocysteine than normal-allele carriers (mean overall Hcy 17.7±10.6 µmol/L; p=0.0334).
Li Y et al
2025 · study_type: observational
observational supports low Spontaneous-abortion cohort (474 women, 235 men): female TT carriers had significantly higher HCY than CC/CT (P=0.002); no such difference in males.
Daghlas I et al
2026 · study_type: observational
observational supports moderate Mendelian-randomization/genetic-association analysis (n=1210 for Hcy-genotype association): C677T associated with higher homocysteine; used as instrument scaling MS risk per SD Hcy increase (OR 0.73, CI 0.66-0.79).

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.